NUV | OVM | NUV / OVM | |
Gain YTD | 2.068 | -1.357 | -152% |
Net Assets | 1.83B | 26.6M | 6,883% |
Total Expense Ratio | 0.47 | 0.83 | 57% |
Turnover | 21.00 | 12.00 | 175% |
Yield | 4.22 | 5.29 | 80% |
Fund Existence | 38 years | 6 years | - |
NUV | OVM | |
---|---|---|
RSI ODDS (%) | 2 days ago70% | 2 days ago56% |
Stochastic ODDS (%) | 2 days ago82% | 2 days ago68% |
Momentum ODDS (%) | 2 days ago69% | 2 days ago46% |
MACD ODDS (%) | 2 days ago76% | 2 days ago53% |
TrendWeek ODDS (%) | 2 days ago70% | 2 days ago66% |
TrendMonth ODDS (%) | 2 days ago74% | 2 days ago66% |
Advances ODDS (%) | 2 days ago76% | 2 days ago67% |
Declines ODDS (%) | 4 days ago76% | 11 days ago65% |
BollingerBands ODDS (%) | 2 days ago83% | 2 days ago44% |
Aroon ODDS (%) | 2 days ago70% | 2 days ago54% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASVYX | 10.27 | 0.07 | +0.69% |
American Century Small Cap Value Y | |||
VITSX | 152.68 | 0.67 | +0.44% |
Vanguard Total Stock Market Idx I | |||
GRLLX | 20.15 | 0.08 | +0.40% |
Goldman Sachs Enhanced U.S. Equity R | |||
PDIAX | 22.54 | 0.07 | +0.31% |
Virtus KAR Equity Income A | |||
FBTCX | 21.71 | N/A | N/A |
Fidelity Advisor Biotechnology C |